Herbalife to expand manufacturing footprint
Direct selling supplements giant Herbalife aims to expand its manufacturing footprint dramatically over the next two-to-four years as it steps up plans to make more of its products in-house.
Direct selling supplements giant Herbalife aims to expand its manufacturing footprint dramatically over the next two-to-four years as it steps up plans to make more of its products in-house.
Researchers from Monell and Givaudan have discovered a ‘taste terminator’ protein inside taste cells, which may control the way we perceive bitter taste signals.
Demand for immune health ingredients in Asia is growing at an annual rate of 6.2 per cent, with revenues expected to reach US$1.46bn in 2016 from US$958.6m in 2009, a research report from consulting and research firm Frost & Sullivan predicted.
An application to allow an extract from the combs of cockerels to be used in dairy products is nearing the end as it is said to pose no significant safety concerns.
An appeal to cut VAT for ice cream has been turned down by the UK government.
The Food and Drug Administration (FDA) has reopened comments on its proposed thresholds for gluten traces in products labeled as gluten free – four years after it originally proposed the guidelines.
The Center for Science in the Public Interest (CSPI) has sent a letter to Food and Drug Administration (FDA) chief Margaret Hamburg, urging a revision of serving size regulations.
Analysts at investment bank Liberum Capital said they expect Unilever to sell its food arm, excluding the ice cream and beverage category, for an estimated figure of €14bn.
A troop of beverage companies in the US, including Coca-Cola, Del Monte and Dole, have made a move to dismiss allegations that their fruit juices contain harmful lead traces.
Food manufacturers in India may have to gradually reduce the salt content in their packaged food products if a proposal from the Indian Council of Medical Research (ICMR) is accepted as a standard.
EFSA health claim opinion
Kraft Foods Europe is “delighted” to have become only the second company to win an article 13.5 health claim but is focusing now on how the opinion will be viewed by the European Commission and member states.